Premium
5‐ASAs in Crohn's disease: are they any better than placebo?
Author(s) -
Ray Shuvra,
Irving Peter
Publication year - 2012
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.952
Subject(s) - medicine , crohn's disease , placebo , disease , base (topology) , intensive care medicine , alternative medicine , pathology , mathematical analysis , mathematics
5‐ASAs are widely employed in the management of Crohn's disease despite limited evidence for their effectiveness. Here, the authors assess the evidence base and current guidance for their use in inducing and maintaining remission in CD.